Results for tag: "Mylotarg"

Mylotarg is a drug used to treat acute myeloid leukemia (AML). It is a type of chemotherapy drug that works by targeting and killing cancer cells. It is administered intravenously and is usually given in combination with other chemotherapy drugs. Mylotarg is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with newly diagnosed AML. It is also approved for the treatment of relapsed or refractory AML in adults and children. The Mylotarg market is a subset of the larger leukemia drugs market. It is a rapidly growing market, driven by the increasing prevalence of AML and the need for more effective treatments. The market is expected to continue to grow in the coming years, as new treatments are developed and approved. Some of the major companies in the Mylotarg market include Pfizer, Novartis, Celgene, and Bristol-Myers Squibb. These companies are involved in the development, manufacture, and marketing of Mylotarg and other leukemia drugs. Show Less Read more